Abstract:Endothelium‐derived engineered extracellular vesicles (LET‐EVs‐miRNA‐125b) are established for the first time, which can target lung tissue and enhance retention. LET‐EVs‐miRNA‐125b can inhibit cell apoptosis, restore cell junctions, and promote proliferation by delivering miRNA‐125b to endothelial cells, which has great potential in the treatment of acute lung injury. Acute lung injury (ALI) is a severe respiratory disease with a high mortality rate. The integrity of the pulmonary endothelial barrier influences the development and prognosis of ALI. Therefore, it has become an important target for ALI treatment. Extracellular vesicles (EVs) are promising nanotherapeutic agents against ALI. Herein, endothelium‐derived engineered extracellular vesicles (eEVs) that deliver microRNA‐125b‐5p (miRNA‐125b) to lung tissues exerting a protective effect on endothelial barrier integrity are reported. eEVs that are modified with lung microvascular endothelial cell‐targeting peptides (LET) exhibit a prolonged retention time in lung tissues and targeted lung microvascular endothelial cells in vivo and in vitro. To improve the efficacy of the EVs, miRNA‐125b is loaded into EVs. Finally, LET‐EVs‐miRNA‐125b is constructed. The results show that compared to the EVs, miRNA‐125b, and EVs‐miRNA‐125b, LET‐EVs‐miRNA‐125b exhibit the most significant treatment efficacy in ALI. Moreover, LET‐EVs‐miRNA‐125b is found to have an important protective effect on endothelial barrier integrity by inhibiting cell apoptosis, promoting angiogenesis, and protecting intercellular junctions. Sequencing analysis reveals that LET‐EVs‐miRNA‐125b downregulates early growth response‐1 (EGR1) levels, which may be a potential mechanism of action. Taken together, these findings suggest that LET‐EVs‐miRNA‐125b can treat ALI by protecting the endothelial barrier integrity.

Extracellular vesicles in the pathogenesis and treatment of acute lung injury

Extracellular vesicles in acute respiratory distress syndrome: Recent developments from bench to bedside

Bidirectional modulation of extracellular vesicle-autophagy axis in acute lung injury: Molecular mechanisms and therapeutic implications

Potential role of extracellular vesicles in acute respiratory distress syndrome

[Role of Different Cells Derived Extracellular Vesicles in Acute Respiratory Distress Syndrome].

The Role of Extracellular Vesicles in Traumatic Brain Injury-induced Acute Lung Injury.

Advances in the use of exosomes for the treatment of ALI/ARDS

Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury

Role of Extracellular Vesicles in Lung Diseases

Role of Extracellular microRNAs in Sepsis-Induced Acute Lung Injury

Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease

Exosomes of different cellular origins: prospects and challenges in the treatment of acute lung injury after burns

Role of extracellular vesicles in severe pneumonia and sepsis

Endothelium‐Derived Engineered Extracellular Vesicles Protect the Pulmonary Endothelial Barrier in Acute Lung Injury

Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome

Extracellular vesicles: mediators of intercellular communication in tissue injury and disease

Mitigation of acute lung injury by human bronchial epithelial cell-derived extracellular vesicles via ANXA1-mediated FPR signaling

Research Progress on the Regulatory Mechanism of Endothelial Derived Extracellular Vesicles in Acute Respiratory Distress Syndrome

Research Progress on Exosome-Mediated Immune Regulation of Acute Lung Injury

Lipidomic Profiling of Bronchoalveolar Lavage Fluid Extracellular Vesicles Indicates Their Involvement in Lipopolysaccharide-Induced Acute Lung Injury

Extracellular vesicles as mediators and markers of acute organ injury: current concepts